NEW YORK (TheStreet) -- Shares of Nu Skin Enterprises (NUS) were falling 12.8% to $43.96 Wednesday after the dietary supplement company guided below analysts' estimates for the fourth quarter, despite its earnings beat for the third quarter.
For the third quarter Nu Skin reported earnings of $1.12 a share, beating the Capital IQ Consensus Estimate of 93 cents a share by 19 cents. Revenue fell 29.7% to $638.8 million, above estimates of $630.07 million.
Looking to the fourth quarter Nu Skin expects earnings of 80 cents to 85 cents a share, below analysts' estimates of $1.01 a share. The company expects revenue of $590 million to $610 million for the fourth quarter, below analysts' estimates of $659.73 million.
Must Read: Warren Buffett's 25 Favorite Stocks
TheStreet Ratings team rates NU SKIN ENTERPRISES as a Buy with a ratings score of B-. TheStreet Ratings Team has this to say about their recommendation:
"We rate NU SKIN ENTERPRISES (NUS) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income."
You can view the full analysis from the report here: NUS Ratings Report